-
Stiripentol (SKU A8704): Reliable LDH Inhibition for Cell As
2026-06-20
Discover how Stiripentol (SKU A8704) streamlines cell viability and cytotoxicity assays through evidence-based lactate dehydrogenase (LDH) inhibition. This article addresses common experimental challenges and demonstrates how this well-characterized compound from APExBIO enables reproducible, data-driven research workflows in neuroscience, oncology, and immunometabolism.
-
Epoxomicin: Precision Proteasome Inhibitor for Pathway Resea
2026-06-19
Epoxomicin, a selective and irreversible proteasome inhibitor, enables researchers to dissect the ubiquitin-proteasome pathway with unmatched specificity, supporting applications from protein degradation assays to inflammation modeling. This article delivers actionable workflows, troubleshooting insights, and protocol parameters tailored for robust, reproducible results.
-
Elbasvir/Grazoprevir: Advancing HCV Therapy in Complex Popul
2026-06-19
This article reviews the 2021 Expert Review of Anti-infective Therapy paper on the fixed-dose combination of elbasvir and grazoprevir for hepatitis C. The study highlights the mechanistic, pharmacological, and clinical advances supporting high SVR rates and safety in diverse HCV patient populations, including those with chronic kidney disease and HIV/HCV coinfection.
-
BML-277: Advanced Chk2 Inhibitor Workflows for DNA Damage Re
2026-06-18
BML-277, a potent and selective Chk2 inhibitor from APExBIO, empowers researchers to precisely dissect DNA damage response pathways and achieve robust radioprotection of T-cells. Discover protocol-driven insights, troubleshooting advice, and the latest experimental advances leveraging BML-277’s unique properties.
-
Leucomycin (Kitasamycin): Molecular Mechanisms and Assay Imp
2026-06-18
Explore the detailed molecular action of Leucomycin (kitasamycin) in translational inhibition studies and antibacterial drug discovery. This article offers new insights into resistance mechanisms and practical assay optimization strategies for advanced research.
-
Morin: Translating Mechanistic Insight Into Mitochondrial In
2026-06-17
This thought-leadership article explores Morin as a mechanistic tool for advancing translational research in diabetic kidney injury, with a focus on mitochondrial energy regulation, AMPD2 inhibition, and dual-use applications as both a cardioprotective and neuroprotective agent and a fluorescent probe. Integrating recent peer-reviewed findings and competitive intelligence, the article provides actionable strategies and protocol guidance for maximizing Morin's impact in disease modeling.
-
CX-5461 Induces DNA Damage and Mitotic Catastrophe in Cervic
2026-06-17
The referenced study demonstrates that CX-5461, a specific RNA polymerase I inhibitor, suppresses cervical cancer cell growth by inducing DNA damage and mitotic catastrophe, and enhances cisplatin sensitivity. These findings highlight Pol I inhibition as a promising strategy for overcoming chemoresistance and improving therapeutic outcomes in cervical cancer.
-
Lysozyme–Amikacin Binding: Mechanistic Insights from Tritium
2026-06-16
This study reveals how lysozyme forms complexes with amikacin, preserving protein structure but abolishing enzymatic activity. Using tritium labeling, fluorescence spectroscopy, and molecular docking, the research clarifies antibiotic-protein interactions relevant for understanding the antibiotic mechanism of action and resistance.
-
4-Ethylphenyl Sulfate in Gut-Brain and Renal Dysfunction Res
2026-06-16
4-Ethylphenyl sulfate stands out as a pivotal tool for modeling gut microbiota-brain interactions and renal dysfunction, bridging molecular insights with translational workflows. Backed by recent advances in understanding metabolite-surface dynamics, this compound enables reproducible, high-fidelity studies on neurobehavioral and renal biomarkers.
-
Clinical Insights into Prochlorperazine-Induced Neuroleptic
2026-06-15
This case study details the diagnostic and therapeutic complexities of neuroleptic malignant syndrome (NMS) induced by prochlorperazine in an elderly patient. The investigation highlights the importance of comprehensive clinical assessment for NMS, especially when typical laboratory findings are absent, and advocates for early pharmacologic intervention to optimize outcomes.
-
Transmission Dynamics of Carbapenemase Genes in Enterobacter
2026-06-15
This study provides an in-depth analysis of carbapenemase-encoding gene (CEG) prevalence and mobility in carbapenem-resistant Enterobacter cloacae across multiple hospitals in Guangdong, China. Through plasmid profiling, genotyping, and conjugation assays, the research reveals extensive multidrug resistance and highlights the significant role of plasmid-mediated blaNDM-1 in gene dissemination—offering critical insights for infection control and antimicrobial research.
-
Amyloid Beta-peptide (25-35): Advancing Neurotoxicity Models
2026-06-14
Amyloid Beta-peptide (25-35) (Aβ25-35) elevates experimental precision in Alzheimer's disease neurotoxicity modeling, enabling robust analysis of microglial polarization and amyloid aggregation. APExBIO’s A1039 delivers batch-to-batch reliability and flexible workflow design, supporting both mechanistic studies and neuroprotective drug screening.
-
Sulfachloropyridazine Modulates Microbiota in E. tenella-Inf
2026-06-13
This study provides a detailed analysis of how sulfachloropyridazine and ethanamizuril, alone and in combination, affect the cecal microbiota and metabolic profile in chickens challenged with Eimeria tenella. The findings reveal drug-specific impacts on both pathogenic bacterial populations and metabolic readouts, offering new insights for research into avian coccidiosis interventions.
-
Auranofin as a Thioredoxin Reductase Inhibitor in Cancer Res
2026-06-12
Auranofin stands out as a gold-standard thioredoxin reductase inhibitor, enabling precision disruption of redox balance and apoptosis induction in cancer and infectious disease models. This article delivers expert workflow guidance, troubleshooting strategies, and practical insights for maximizing Auranofin’s utility in advanced redox and radiosensitization studies.
-
Azathramycin A: Macrolide Antibiotic for Tuberculosis Models
2026-06-12
Azathramycin A, a specialized macrolide antibiotic, enables precise modeling of Mycobacterium tuberculosis protein synthesis inhibition and resistance mechanisms. Its high solubility and ribosomal targeting make it an indispensable tool for advanced tuberculosis antibacterial research and experimental optimization.